9-132905861-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_000368.5(TSC1):c.1717C>A(p.Gln573Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,612,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q573P) has been classified as Uncertain significance.
Frequency
Consequence
NM_000368.5 missense
Scores
Clinical Significance
Conservation
Publications
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- lung lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000368.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | NM_000368.5 | MANE Select | c.1717C>A | p.Gln573Lys | missense | Exon 15 of 23 | NP_000359.1 | ||
| TSC1 | NM_001406592.1 | c.1717C>A | p.Gln573Lys | missense | Exon 15 of 23 | NP_001393521.1 | |||
| TSC1 | NM_001406593.1 | c.1717C>A | p.Gln573Lys | missense | Exon 15 of 23 | NP_001393522.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | ENST00000298552.9 | TSL:1 MANE Select | c.1717C>A | p.Gln573Lys | missense | Exon 15 of 23 | ENSP00000298552.3 | ||
| TSC1 | ENST00000490179.4 | TSL:3 | c.1717C>A | p.Gln573Lys | missense | Exon 16 of 24 | ENSP00000495533.2 | ||
| TSC1 | ENST00000643875.1 | c.1717C>A | p.Gln573Lys | missense | Exon 15 of 23 | ENSP00000495158.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 251006 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460420Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726276 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74370 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The p.Q573K variant (also known as c.1717C>A), located in coding exon 13 of the TSC1 gene, results from a C to A substitution at nucleotide position 1717. The glutamine at codon 573 is replaced by lysine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at